The Valley Desk

NCT02100228 · Interventional trial

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

Overall registry status Completed

Phase 4

Conditions Atrial Fibrillation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov